- Research
- Scientific Innovation
- Centers of Distinction
- Current Studies
- Researchers
- Publications
- Research News and Stories
- Brainerd Lakes Clinic
- International Cardiac Outreach, Research and Education (ICORE)
- Running with a mission
- Safer CT Scans
- Sickle Cell Trait and Sudden Death in Young Athletes
- Stem Cell Promise for Angina
- Sudden death in triathlons
- TRANSLATE-ACS Team Recognized
- MHIF Researchers Awarded $2 Million Grant
- Education
- Community Outreach
- News and Events
- About Us
- Donate Now
Riata ICD Lead Summit
Friday, January 20, 2012
To access the archived presentations and videos, you must first register or login.
Summit Agenda
Introduction & Goals
David L. Hayes, MD
Riata Leads: What do we know, what are the questions?
Robert G. Hauser, MD
The Northern Ireland Experience
Ernest W. Lau, MD
The Independent Multicenter Study: Preliminary Results
Raed. H. Abdelhadi, MD
Lead Survival: VA National Cardiac Device Surveillance Experience
Edmund C. Keung, MD
St. Jude's Perspective
Mark D. Carlson, MD
Panel Session: Clinical Experiences with Riata Leads
David L. Hayes, MD, Chair; Drs. Saba, Epstein, DiMarco, Trohman, Friedman, Swerdlow, Kramer, Lau and Love, and Melanie Gura, RN
Fluroscopic Examination of Riata Leads
Christopher R. Ellis, MD
Riata Lead Extraction: Methods and Results
Laurence M. Epstein, MD
Riata Clinical Follow-up: Diagnostic Data and Measurements
Ken A. Ellenbogen, MD
Remote Follow-Up: What are the options?
Charles D. Swerdlow, MD
Panel Session: Patient Management
David L. Hayes, MD, Chair; Drs. Carrillo, Vatterott, Bazaz, Swerdlow, Epstein, Ellenbogen, DiMarco and Love, and Linda Kallinen Retel
Summary and Consensus
David L. Hayes, MD and Robert G. Hauser, MD

Conference Overview
Approximately 80,000 active patients have Riata or Riata ST ICD leads in the U.S. These leads have exhibited externalized cables whereby the cables appear outside the lead body on fluoroscopy. Leads with externalized cables may be functioning normally and electrically intact, or there may be signs of noise, oversensing, or threshold or impedance changes. Therefore it is not clear how patients with these leads should be managed.
The purpose of this one-day Riata ICD Lead Summit is to review the available data and develop a consensus regarding patient management, including follow-up and approaches to leads that have failed and require replacement.
Time & Place
Time: Friday, January 20, 2012, 8:00 a.m. – 4:30 p.m. (CST)
Place: Minneapolis Airport Marriott (near the Mall of America)
2020 American Blvd E., Bloomington, MN
Learning Objectives
- Discuss Riata ICD lead performance
- Explain monitoring of Riata ICD lead functions
- Develop strategy for long-term follow-up of patients with Riata ICD leads
- Define areas for future study
Printable Event Brochure
Target Audience
Restricted to physicians and allied health professionals who care for ICD patients.
Summit Directors
Robert G. Hauser, MD
President, Cardiovascular Services, Allina Hospitals & Clinics
David L. Hayes, MD
Professor of Medicine, Mayo Clinic
Faculty
Raed H. Abdelhadi, MD
Minneapolis Heart Institute® at Abbott Northwestern Hospital
Samuel J. Asirvatham, MD
Mayo Clinic
Raveen R. Bazaaz, MD
Atrial Arrhythmia Center, University of Pittsburgh
Mark D. Carlson, MD
St. Jude Medical, Inc.
Roger G. Carrillo, MD
University of Miami Health System
John P. DiMarco, MD
University of Virginia Health System
Kenneth A. Ellenbogen, MD
Pauley Heart Center, Virginia Commonwealth University
Christopher R. Ellis, MD
Vanderbilt Heart and Vascular Institute
Laurence M. Epstein, MD
Brigham and Women’s Hospital
Paul A. Friedman, MD
Mayo Clinic
Melanie T. Gura, RN
Northeast Ohio Cardiovascular Specialists
Linda M. Kallinen Retel, BS
Minneapolis Heart Institute® at Abbott Northwestern Hospital
Daniel B. Kramer, MD
Beth Israel Deaconess Medical Center
Ernest W. Lau, MD
Royal Victoria Hospital
Charles J. Love, MD
The Dorothy M. Davis Heart and Lung Research Institute
Samir F. Saba, MD
University of Pittsburgh Medical Centerw
Charles D. Swerdlow, MD
Cedars-Sinai Medical Center
Richard G. Trohman, MD
Rush University Medical Center
Pierce J. Vatterott, MD
United Heart and Vascular Clinic
Registration & Logistics
Tuition
$125
Tuition fee includes educational credits, conference materials, parking and refreshments. The online registration website will accept payments by bank or credit card. Conference registrations will be capped to ensure a comfortable learning environment for attendees. Early registration is recommended.
Cancellation and Refund Policy
Substitutions are accepted at any time. For cancellations received a minimum of one week before the event date, a $50 processing fee will be retained and the tuition balance refunded. Notices after this date will not receive a refund. To complete your cancellation or substitution call 612-863-6236 or email alyle@mhif.org. In the unlikely event the program is cancelled, MHIF is not responsible for airfare, hotel or other costs incurred by participants.
Questions
For questions about the conference, please call Ashley Lyle at 612-863-6236 or email alyle@mhif.org.
Accreditation
Allina Hospitals & Clinics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allina Learning & Development, Office of Accreditation at Allina Hospitals & Clinics designates this live educational activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

